At the start of the year Sebastián Piñera, president of Chile, went to Santiago airport personally to greet a consignment of vaccines from China. ‘Today is a day of joy, excitement and hope,’ he said from a podium on the tarmac. ‘As you see behind me, there is the plane that brought a shipment of almost two million doses of Sinovac vaccines.’ By April, Chile had suffered one of the worst Covid surges in Latin America. The joy and hope, it seemed, had been misplaced.
A few weeks ago, Chile’s government announced that, after a real-world study involving 10.5 million Chileans, Sinovac turned out to be only 16 per cent effective at reducing the risk of infection after one shot and 67 per cent effective two weeks after the second dose. Even Chile’s fast-paced vaccine programme — it is more extensive than Britain’s — has not been enough to prevent a new wave and a new lockdown.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in